First Diagnostics UTI Crowdfund Projects Launched by LISA
In Response to FDA Final LDT Rule – First Diagnostics UTI Crowdfund Projects Launched Goal to Bring CAP/COLA Labs Together for Innovative FDA-Compliant Assays Carlsbad, CA- October 22, 2024- The Laboratory Integration Strategic Association (LISA) proudly announces the first crowdfund projects that empower labs to navigate the evolving FDA regulatory landscape for Laboratory Developed Tests […]
Crowdfunding: An Urgent Solution for Labs Facing FDA’s Final LDT Rule
FDA’s Final LDT Rule – Stricter Regulatory Requirements In his recently published white paper on Today’s Clinical Lab, James Gilmore, CEO of The Laboratory Integration Strategic Association (LISA), emphasizes increasing urgency for CAP/COLA laboratories as FDA’s Final Rule on Laboratory-Developed Tests (LDTs) takes hold. With the rule introducing stricter regulatory requirements, many labs will face […]
First-Ever Crowdfunding Effort for Diagnostic Assays Launched in Response to FDA’s Final LDT Rule
LISA CEO James Gilmore reveals why the crowdfunding effort for diagnostic assays is a game-changing strategy for managing the new regulatory costs associated with laboratory-developed tests (LDTs). As the FDA’s final rule on Laboratory-Developed Tests (LDTs) reshapes the regulatory landscape, James Gilmore, CEO of the Laboratory Integration Strategic Association (LISA), is spearheading a revolutionary initiative […]